ReviewCancers2026
Clinical AI in Radiology: Foundations, Trends, Applications, and Emerging Directions.
Review in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Patients' Perspectives on Applications of AI and Personalized Medicine in Life-Threatening Heart Disease: European Cross-Sectional Patient Questionnaire Study.Journal of medical Internet research · 2026Article
- Human-AI Interaction in Interventional Radiology: A Narrative Review of Current Applications, Challenges, and Future Directions.Journal of imaging · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Artificial intelligence (AI) is at the vanguard of transforming radiology in several ways, including augmenting diagnoses, improving workflows, and increasing operational efficiency. Several integration challenges, including concerns over privacy, clinical usability, and workflow compatibility, still remain. This review discusses the foundations and current trends of clinical AI in radiology to provide essential context for ongoing developments. To illustrate translational potential, we describe representative applications, including: (1) local deployment of large language models (LLMs) for restructuring and streamlining radiology reports, improving clarity and consistency without relying on external resources; (2) multimodal AI frameworks combining CT images, clinical data, laboratory biomarkers, and LLM-extracted features from clinical notes for early detection of cachexia in pancreatic cancer; (3) privacy-preserving federated learning (FL) infrastructure enabling collaborative AI model development across institutions without sharing raw patient data; and (4) an uncertainty-aware de-identification pipeline for removing Protected Health Information (PHI) from radiology images and clinical reports to support secure data analysis and sharing. We further discuss emerging opportunities for tumor board decision support, clinical trial matching, radiology report quality assurance, and the development of an imaging complexity index. Collectively, these applications highlight the importance of local deployment, multimodal reasoning, privacy preservation, and human-in-the-loop oversight in translating AI models from research to oncology radiology practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.